In Brief: Influence, Inc.
This article was originally published in The Gray Sheet
Influence, Inc.: Firm's Influ-ENT division launches the Repose surgical system for treatment of obstructive sleep apnea and snoring. The minimally invasive chin bone screw system is intended for use in stabilizing the tongue and preventing it from "collapsing back and obstructing the airway passage," Influence states in a Feb. 3 release. Formerly named the Sleep-In, the device was cleared via 510(k) Aug. 25. The launch was delayed until three-month post-treatment sleep study data could be accumulated and compared to pre-treatment data, Influence explains...
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.